LITTLE KNOWN FACTS ABOUT MBL77.

mutations presented the fact that, as discussed below, CLL therapy relies on the presence or absence of those mutations. The existing consensus is, in addition to clonal mutations, subclonal mutations using a variant allelic frequency starting from five to ten% (and so down below the brink of detection by conventional molecular techniques) may be r